Chung; Shin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chung; Shin.The latest application filed is for "hif 1-alpha antisense oligonucleotides".

Company Profile

4.9.14

Chung; Shin - Yongin-si KR
Chung; Shin - Gyounggi-do KR
Chung; Shin - Gyeonggi-do KR
Chung; Shin - Kyongki-Do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HIF 1-alpha antisense oligonucleotides Grant 11,319,540 - Chung , et al. May 3, 2	2022-05-03
SCN9A antisense pain killer Grant 11,162,104 - Chung , et al. November 2, 2	2021-11-02
Hif 1-alpha Antisense Oligonucleotides App 20210292767 - Chung; Shin ; et al.	2021-09-23
Androgen Receptor Antisense Oligonucleotides App 20190345202 - Chung; Shin ; et al.	2019-11-14
Exon Skipping By Peptide Nucleic Acid Derivatives App 20190337987 - Chung; Shin ; et al.	2019-11-07
Scn9a Antisense Pain Killer App 20190338292 - Chung; Shin ; et al.	2019-11-07
Scn9a Antisense Oligonucleotides App 20190218255 - Chung; Shin ; et al.	2019-07-18
Cosmetic Composition For Improving Health Of Scalp And Method Of Preparing The Same App 20170340544 - CHUNG; Shin ; et al.	2017-11-30
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid Grant 8,895,734 - Chung , et al. November 25, 2	2014-11-25
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid Grant 8,884,008 - Chung , et al. November 11, 2	2014-11-11
Peptide Nucleic Acid Derivatives With Good Cell Penetration And Strong Affinity For Nucleic Acid App 20140323728 - CHUNG; Shin ; et al.	2014-10-30
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid Grant 8,859,766 - Chung , et al. October 14, 2	2014-10-14
Peptide Nucleic Acid Derivatives With Good Cell Penetration And Strong Affinity For Nucleic Acid App 20140155605 - CHUNG; Shin ; et al.	2014-06-05
Peptide Nucleic Acid Derivatives With Good Cell Penetration And Strong Affinity For Nucleic Acid App 20140155604 - CHUNG; Shin ; et al.	2014-06-05
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid Grant 8,680,253 - Lee , et al. March 25, 2	2014-03-25
Peptide Nucleic Acid Derivatives With Good Cell Penetration And Strong Affinity For Nucleic Acid App 20120040918 - Lee; Jong-Ook ; et al.	2012-02-16
2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-.alpha. Grant 8,013,187 - Kim , et al. September 6, 2	2011-09-06
Peptide Nucleic Acid Derivatives With Good Cell Penetration And Strong Affinity For Nucleic Acid App 20110178031 - Lee; Jong-Ook ; et al.	2011-07-21
Dual Inhibition Of Cyclooxygenase-2 And Carbonic Anhydrase App 20100069483 - PARK; Mi-Young ; et al.	2010-03-18
Dosing Regimens for Cox-2 Inhibitor App 20080306146 - Lim; Kyung-Min ; et al.	2008-12-11
Dual inhibition of cyclooxygenase-2 and carbonic anhydrase App 20050222251 - Park, Mi-Young ; et al.	2005-10-06
Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors Grant 5,476,847 - McKittrick , et al. December 19, 1	1995-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.